Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open‐label safety study
Michael R. Sperling, Pavel Klein, Sami Aboumatar, et al.
Epilepsia (2020) Vol. 61, Iss. 6, pp. 1099-1108
Open Access | Times Cited: 158

Showing 1-25 of 158 citing articles:

Adjunctive cenobamate in highly active and ultra‐refractory focal epilepsy: A “real‐world” retrospective study
Javier Peña‐Ceballos, Patrick B. Moloney, Tudor Munteanu, et al.
Epilepsia (2023) Vol. 64, Iss. 5, pp. 1225-1235
Open Access | Times Cited: 55
Real‐world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access Program
Vicente Villanueva, Daniel Santos‐Carrasco, Pablo Cabezudo‐García, et al.
Epilepsia Open (2023) Vol. 8, Iss. 3, pp. 918-929
Open Access | Times Cited: 52
Drug Reaction with Eosinophilia and Systemic Symptoms
Kimberly G. Blumenthal, Adela R. Cardones, Daniela Kroshinsky
New England Journal of Medicine (2025) Vol. 392, Iss. 9, pp. 933-935
Closed Access | Times Cited: 3
Pharmacology of Cenobamate: Mechanism of Action, Pharmacokinetics, Drug–Drug Interactions and Tolerability
Roberta Roberti, Carmen De, Luigi Francesco Iannone, et al.
CNS Drugs (2021) Vol. 35, Iss. 6, pp. 609-618
Closed Access | Times Cited: 95
Idiosyncratic Drug-Induced Liver Injury: Mechanistic and Clinical Challenges
Alison Jee, Samantha Christine Sernoskie, Jack Uetrecht
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 2954-2954
Open Access | Times Cited: 78
Long-term Efficacy and Safety From an Open-Label Extension of Adjunctive Cenobamate in Patients With Uncontrolled Focal Seizures
Pavel Klein, Sami Aboumatar, Christian Brandt, et al.
Neurology (2022) Vol. 99, Iss. 10
Open Access | Times Cited: 62
The ups and downs of alkyl‐carbamates in epilepsy therapy: How does cenobamate differ?
Wolfgang Löscher, Graeme J. Sills, H. Steve White
Epilepsia (2021) Vol. 62, Iss. 3, pp. 596-614
Open Access | Times Cited: 57
Dose Adjustment of Concomitant Antiseizure Medications During Cenobamate Treatment: Expert Opinion Consensus Recommendations
Michael C. Smith, Pavel Klein, Gregory L. Krauss, et al.
Neurology and Therapy (2022) Vol. 11, Iss. 4, pp. 1705-1720
Open Access | Times Cited: 50
Update on Antiseizure Medications 2022
Bassel Abou‐Khalil
CONTINUUM Lifelong Learning in Neurology (2022) Vol. 28, Iss. 2, pp. 500-535
Closed Access | Times Cited: 45
Recent advances in pharmacotherapy for epilepsy
Amanda W. Pong, Kevin J. Xu, Pavel Klein
Current Opinion in Neurology (2023) Vol. 36, Iss. 2, pp. 77-85
Closed Access | Times Cited: 43
New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: I. Role of GABA as a Modulator of Seizure Activity and Recently Approved Medications Acting on the GABA System
Emilio Perucca, Meir Bialer, H. Steve White
CNS Drugs (2023) Vol. 37, Iss. 9, pp. 755-779
Open Access | Times Cited: 42
Animal Models of Drug-Resistant Epilepsy as Tools for Deciphering the Cellular and Molecular Mechanisms of Pharmacoresistance and Discovering More Effective Treatments
Wolfgang Löscher, H. Steve White
Cells (2023) Vol. 12, Iss. 9, pp. 1233-1233
Open Access | Times Cited: 38
Failure to use new breakthrough treatments for epilepsy
Pavel Klein, Gregory L. Krauss, Bernhard J. Steinhoff, et al.
Epilepsia (2023) Vol. 64, Iss. 6, pp. 1458-1465
Closed Access | Times Cited: 24
The cenobamate KORK study—A prospective monocenter observational study investigating cenobamate as an adjunctive therapy in refractory epilepsy, with comparisons to historical cohorts treated with add‐on lacosamide, perampanel, and brivaracetam
Bernhard J. Steinhoff, Dimitra Georgiou, Tassanai Intravooth
Epilepsia Open (2024) Vol. 9, Iss. 4, pp. 1502-1514
Open Access | Times Cited: 10
Cenobamate as an Early Adjunctive Treatment in Drug-Resistant Focal-Onset Seizures: An Observational Cohort Study
Yaroslav Winter, Raya Abou Dargham, Susana Patiño Tobón, et al.
CNS Drugs (2024) Vol. 38, Iss. 9, pp. 733-742
Open Access | Times Cited: 10
Reductions in concomitant antiseizure medication drug load during adjunctive cenobamate therapy: Post-hoc analysis of a subset of patients from a phase 3, multicenter, open-label study
Sami Aboumatar, Louis Ferrari, Sean Stern, et al.
Epilepsy Research (2024) Vol. 200, pp. 107306-107306
Open Access | Times Cited: 9
Cenobamate: real-world data from a retrospective multicenter study
Stephan Lauxmann, David Heuer, Jan Heckelmann, et al.
Journal of Neurology (2024) Vol. 271, Iss. 10, pp. 6596-6604
Open Access | Times Cited: 9
Cenobamate as add‐on treatment for SCN8A developmental and epileptic encephalopathy
Cathrine E. Gjerulfsen, Madeleine J. Oudin, Francesca Furia, et al.
Epilepsia (2025)
Closed Access | Times Cited: 1
Real‐world use of cenobamate in adults: Efficacy and predictors of treatment response
Itai Loushy, Lilach Goldstein, Kathryn N. Devlin, et al.
Epilepsia (2025)
Closed Access | Times Cited: 1
A multicenter cohort study on the efficacy, retention, and tolerability of cenobamate in patients with developmental and epileptic encephalopathies
Elisa Buhleier, Susanne Schubert‐Bast, Susanne Knake, et al.
Epilepsia (2025)
Open Access | Times Cited: 1
Post-marketing Experience with Cenobamate in the Treatment of Focal Epilepsies: A Multicentre Cohort Study
Adam Strzelczyk, Felix von Podewils, Hajo M. Hamer, et al.
CNS Drugs (2025)
Open Access | Times Cited: 1
Exploring the Effectiveness of Adjunctive Cenobamate in Focal Epilepsy: A Time-Based Analysis
Roberta Roberti, Gianfranco Di Gennaro, Vittoria Cianci, et al.
CNS Drugs (2025)
Open Access | Times Cited: 1
Successful treatment of pediatric patient with Dravet syndrome with cenobamate: Case report
Oleg V. Lobanov, Mary Bertrand
SAGE Open Medical Case Reports (2025) Vol. 13
Open Access | Times Cited: 1
Cenobamate (XCOPRI): Can preclinical and clinical evidence provide insight into its mechanism of action?
Michelle Guignet, Amanda Campbell, H. Steve White
Epilepsia (2020) Vol. 61, Iss. 11, pp. 2329-2339
Closed Access | Times Cited: 60
Page 1 - Next Page

Scroll to top